Korea-Japan joint new drug development and natural ingredient consulta…
페이지 정보
작성자 ㈜MST 조회1,095 View 작성일 18-11-28 09:53본문
Korea-Japan joint new drug development and natural ingredient consultation.
In November 2018, we MST(KOREA) CO., LTD.(CEO Woong-Sig Moon·www.BioCleanAct.com·BrandName: BioCleanAct™) held an invitation to invite buyers in Tokyo, Japan.
Consultation contents:
Korea-Japan Natural Products New Drug Development Agreement
Consultation on the sales of natural products in Japan
We hold buyer meeting of functional raw materials derived from natural materials.
CEO/Chairman
Woong-Sig Moon,right